keppra 100 mg/ml solution buvable
ucb-pharma sa - levetiracetamum - solution buvable - levetiracetamum 100 mg, natrii citras dihydricus, acidum citricum monohydricum, glycerolum (85 per centum), maltitolum liquidum 300 mg, aqua purificata, aromatica, ammonii glycyrrhizas, acesulfamum kalicum, propylis parahydroxybenzoas 0.3 mg, e 218 2.7 mg ad solutionem pro 1 ml corresp. natrium < 23 mg. - antiepileptikum - synthetika
levofloxacin labatec i.v. 500 mg/100 ml solution pour perfusion
labatec pharma sa - levofloxacinum - solution pour perfusion - levofloxacinum 500 mg ut levofloxacinum hemihydricum, natrii chloridum, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 100 ml corresp. natrium max. 377.05 mg. - infektionskrankheiten - synthetika
signifor 0.3 mg/1 ml injektionslösung
recordati ag - pasireotidum - injektionslösung - pasireotidum 0.3 mg ut pasireotidi diaspartas, mannitolum, acidum tartaricum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - behandlung von cushing ' s disease - synthetika
signifor 0.6 mg/1 ml injektionslösung
recordati ag - pasireotidum - injektionslösung - pasireotidum 0.6 mg ut pasireotidi diaspartas, mannitolum, acidum tartaricum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - behandlung von cushing ' s disease - synthetika
signifor 0.9 mg/1 ml injektionslösung
recordati ag - pasireotidum - injektionslösung - pasireotidum 0.9 mg ut pasireotidi diaspartas, mannitolum, acidum tartaricum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - behandlung von cushing ' s disease - synthetika
briviact 10 mg/ml solution buvable
ucb-pharma sa - brivaracetamum - solution buvable - brivaracetamum 50 mg, acidum citricum, natrii citras dihydricus, carmellosum natricum, sucralosum, sorbitolum 839.5 mg, glycerolum, aromatica, aqua purificata, e 218 5 mg ad solutionem pro 5 ml corresp. natrium 5.8 mg. - antiépiléptique - synthetika
viferol d3 100'000 ui / ml solution buvable
om pharma suisse sa - cholecalciferolum - solution buvable - cholecalciferolum 100000 u.i., e 306, aurantii dulcis flavedinis aetheroleum, polyglyceroli-3 dioleas, olivae oleum raffinatum q.s. ad solutionem pro 1 ml. - zubereitung vitamin d - synthetika
vi-de 3 dose par mois solution buvable
verfora sa - cholecalciferolum - solution buvable - cholecalciferolum 600 µg, polysorbatum 20, aqua purificata, glycerolum, ethanolum 96 per centum, ad solutionem pro 5 ml corresp. ethanolum 65 % v/v. - préparation de vitamine d - synthetika
phenylephrin aguettant 0.05 mg/ml solution injectable en seringue préremplie
aguettant suisse sa - phenylephrinum - solution injectable en seringue préremplie - phenylephrinum 0.05 mg ut phenylephrini hydrochloridum, natrii chloridum, acidum citricum monohydricum, natrii citras dihydricus, natrii hydroxidum ad ph, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 3.68 mg. - sympathomimetika - synthetika
ganirelix labatec 0,25 mg solution injectable en seringue préremplie
labatec pharma sa - ganirelixum - solution injectable en seringue préremplie - ganirelixum 0.25 mg ut ganirelixi acetas, acidum aceticum glaciale, mannitolum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.023 mg. - médecine de reproduction assistée - synthetika